The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer’s disease (AD). Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.